Literature DB >> 32419708

COVID-19 and Guillain-Barré syndrome: Response.

Jean-Philippe Camdessanché¹, Jérôme Morel², Bruno Pozzetto³, Stéphane Paul⁴, Yannick Tholance⁵, Elisabeth Botelho-Nevers⁶.

Abstract

Entities: Disease Species

Mesh：

Year: 2020 PMID： 32419708 PMCID： PMC7225720 DOI： 10.1016/j.neurol.2020.05.003

Source DB: PubMed Journal: Rev Neurol (Paris) ISSN： 0035-3787 Impact factor: 2.607

× No keyword cloud information.

We thank Beuy Joob and Viroj Wiwanitkit for their comment about our article [1]. When we sent the paper to the Revue Neurologique (Paris), only one paper had been published. In this case report, the link between Guillain-Barré syndrome and COVID-19 was uncertain [2]. In our patient, no rash was present and the patient had not travelled in endemic areas for Dengue, reason why this diagnosis had not been discussed.

Disclosure of interest

The authors declare that they have no competing interest.

2 in total

1. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Authors: Hua Zhao; Dingding Shen; Haiyan Zhou; Jun Liu; Sheng Chen
Journal: Lancet Neurol Date: 2020-04-01 Impact factor: 44.182

2. COVID-19 may induce Guillain-Barré syndrome.

Authors: J-P Camdessanche; J Morel; B Pozzetto; S Paul; Y Tholance; E Botelho-Nevers
Journal: Rev Neurol (Paris) Date: 2020-04-15 Impact factor: 2.607

2 in total

1. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.

Authors: Thomas Pfefferkorn; Rainer Dabitz; Thomas von Wernitz-Keibel; Johannes Aufenanger; Martina Nowak-Machen; Hendrik Janssen
Journal: J Neurol Date: 2020-05-12 Impact factor: 4.849

2. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.

Authors: David Salomón Juliao Caamaño; Rubén Alonso Beato
Journal: J Clin Neurosci Date: 2020-05-14 Impact factor: 1.961

2 in total